09:00 | Opening | Helge Sander (Danish Minister for Science, Technology and Innovation) | |
09:15 | Plenary | PL4: Targeted Nanodrugs: The Drugs of the 21 Century? Science, Technology and Selection of the Optimal Commercialization Venue Chair: TL Andresen Co-chair: RH Berg | |
10:00 | Plenary | PL5: Ultra High Throughput Sequencing: Technology and Applications Chair: RH Berg Co-chair: TL Andresen | |
10:45 - Coffee Break
Session 4 | Nanomedicine Chair: TL Andresen - 4A | The Role of Micro-Nanotechnology Competence Centers Chair: V. Saile - 4B | MNT for Sustainable Energy and Environment Chair: D. Tolfree - 4C |
|---|---|---|---|
11:15 | Julianna Lisziewicz (Invited) 4A1: pDNA/PEIm Immunotherapeutic Nanomedicine: From the Discovery to the Clinic
Gregor Cevc (Invited) 4A2: From a Syringe to Smart, Soft Skin-Penetrators: Nanotechnology for Drug Delivery Across the Skin | Huub Salemink (Invited) 4B1: Nanoscience and Technology in Netherlands: Experiences with the NanoNed Consortium
Thomas Bjørnholm (Invited) 4B2: Eight Years Experience in Nanotechnology Transfer Between Industry and University | Clive Davenport (Invited) 4C1: Plastic Banknotes to Printed Solar Cells: Printing the New Currency!
Seamus Curran (Invited) 4C2: Alternative Energy and the Impact of Nanoscience
|
12:30 - Lunch
13:30 | Plenary | PL6: Shape Effects & "Self" Ligands - Delaying Clearance of Polymeric Self-Assemblies to Maximize Dose Chair: TL Andresen | |
Session 5 | MNT for Drug Delivery and Diagnostics Chair: DH Thompson - 5A | Tools & Technologies Chair: T Bjørnholm - 5B | Business Models, Roadmapping and Corporate Responsibility Chair: C Davenport - 5C |
|---|---|---|---|
14:15 | Simon Benita (Invited) 5A1: Translating Original Ideas into Nanotherapeutic Products: The Academia-Industry Interface Challenge
Samir Mitragotri (Invited) 5A2: Designer Micro and Nanoparticles for Drug Delivery
| Katsuaki Suganuma (Invited) 5B1: Ag Nano-Ink Wiring for Printed Electronics
Johan Liu (Invited) 5B2: Development and Challenges in Commercialization of New Nanotechnology Based Materials for Microsystem Heat Dissipation Applications
Anthony A. Robson 5B3: Food Nanotechnology and Health: Creating Bioavailable Nutrient-Rich, Low-Energy-Dense Diets
| Steven Walsh 5C1: Towards a Metric Management Approach for Multi-Emerging Technology Based Fabrication Facilities
James Wylde 5C2: The Integrated Smart Approach to Product Development - A Revolution in Accelerating Time-to-Market for Nanotechnology Enabled Products
David Tollfree 5C3: Roadmaping - A Tool for Commercialising Micro-Nanotechnology Products
Christopher Groves 5C4: Regulating Nanotechnology: Is There Room at the Bottom for Corporate Social Responsibility?
Sul Kassicieh 5C5: Analysis of Investments in Micro and Nano-technology 1995-2009 |
15:30 - Coffee Break and Poster Session
Session 6 | MNT for Drug Delivery and Diagnostics Chair: Y Barenholz Co-chair: TL Andresen - 6A | Innovation and IP Issues Chair: B Brox Co-chair: M Eibpoosh - 6B | Microfluidics Chair: H. van Heeren Co-chair: P Salomon - 6C |
|---|---|---|---|
16:15 | David H. Thompson (Invited) 6A1: Efforts to Develop a High-Throughput Supported Membrane Screening Tool Using Isoprenylcarboxyl Methyltransferase-Based Proteoliposomes
6A2: Visualizing Nanomedicine Biodistribution by Positron Emission Tomography
Erol Harvey 6A3: Challenges in Developing and Commercializing Point-of-Care Diagnostics
6A4: NanoBioPores: Basic Nano/MEMS Structures for Electrochemical Analysis of Chemical and Biochemical Reactions
Andreas Kunding 6A5: Lipid Vesicles as Model Systems for Drug Delivery
David Wenn 6A6: A Platform for Smart Integrated Biodagnostic Systems | Karen Laigaard (Invited) 6B1: Technology Transfer - Challenges and Opportunities
Bill Brox (Invited) 6B2: One Example of Investing in Intellectual Assets
Christine Neuy 6B3: Innovation Through Highly Skilled Workforce: Overcoming the Crisis
Dirk Ortloff 6B4: Process Development Challenges in Difficult Economic Times
James B. Tuttle 6B5: Technology Transfer Another Way | Henne van Heeren (Invited) 6C1: Microfluidic Success in Hotspots or in Niche Applications?
Detlef Snakenborg 6C2: Re-Configurable Modular System for Microfluidic Applications
Jochen Hoffmann 6C3: Two Microfluidic Platforms for Miniaturization, Integration and Automation of Assays
Martin Jensen Søe 6C4: Time-Lapse Study of Hybridization Kinetics in Tissue Sections - Decreasing Slide to Slide Variation Using Flow in Microfluidic Chambers
David Sabourin 6C5: Peristaltic Micropump for Microfluidic Applications
Stig Morten Borch 6C6: In Vitro Diagnostic Platforms of the Future - Technological Challenges and Possibilities
|
19:00 - Conference Ball (awards)
A - Audience • B - First Floor 101 • C - Second Floor 202